What if there was a simple blood test that could detect and screen for multiple cancers at once? This is what researcher's across the country are trying to learn in the Vanguard Study! We are looking ...
PepGen (PEPG) announced positive clinical data from the 15 mg/kg dose cohort of its ongoing FREEDOM-DM1 Phase 1 single ascending dose study in patients with myotonic dystrophy type 1. These latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback